Epidemiology of systemic lupus erythematosus: an update
- PMID: 29251660
- PMCID: PMC6026543
- DOI: 10.1097/BOR.0000000000000480
Epidemiology of systemic lupus erythematosus: an update
Abstract
Purpose of review: Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease with a significant disease burden across the world among different ethnic, racial, and age groups. The pathophysiological understanding of SLE is constantly evolving and with it, the need for a better definition of the disease itself, for understanding the risk among the different affected populations, and for identifying the factors responsible for the damage accrual through the years.
Recent findings: More accurate estimates of incidence and prevalence of SLE among different ethnicities and minority groups not only in the USA, but also in Europe, Middle East, and Asia have provided new insights into the disease burden around the world. Despite advances in treatment, mortality among SLE patients remains high with significant ethnic and geographic variations.
Summary: Sex, race, and ethnicity significantly affect SLE incidence, prevalence, and mortality.
Similar articles
-
Global epidemiology of systemic lupus erythematosus.Nat Rev Rheumatol. 2021 Sep;17(9):515-532. doi: 10.1038/s41584-021-00668-1. Epub 2021 Aug 3. Nat Rev Rheumatol. 2021. PMID: 34345022 Free PMC article. Review.
-
Epidemiology of systemic lupus erythematosus.Expert Rev Clin Immunol. 2017 Aug;13(8):799-814. doi: 10.1080/1744666X.2017.1327352. Epub 2017 May 16. Expert Rev Clin Immunol. 2017. PMID: 28471259 Review.
-
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.Lupus. 2006;15(5):308-18. doi: 10.1191/0961203306lu2305xx. Lupus. 2006. PMID: 16761508 Review.
-
Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region.Arthritis Care Res (Hoboken). 2022 Feb;74(2):187-198. doi: 10.1002/acr.24431. Epub 2022 Jan 10. Arthritis Care Res (Hoboken). 2022. PMID: 32841537 Review.
-
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies.Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961. doi: 10.1093/rheumatology/kex260. Rheumatology (Oxford). 2017. PMID: 28968809 Review.
Cited by
-
Predictors of flare-related inpatient or emergency department stay in systemic lupus erythematosus: A real-world analysis of Medicaid claims in the United States.J Manag Care Spec Pharm. 2024 Jan;30(1):61-70. doi: 10.18553/jmcp.2024.30.1.61. J Manag Care Spec Pharm. 2024. PMID: 38153861 Free PMC article.
-
Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.J Clin Med. 2021 May 6;10(9):1992. doi: 10.3390/jcm10091992. J Clin Med. 2021. PMID: 34066436 Free PMC article. Review.
-
Oral Lesion Management in Juvenile SLE with Hepatosplenomegaly.Int Med Case Rep J. 2024 Jul 23;17:695-702. doi: 10.2147/IMCRJ.S476377. eCollection 2024. Int Med Case Rep J. 2024. PMID: 39076507 Free PMC article.
-
Implications of CD154 and Its Receptors in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.Cells. 2024 Sep 28;13(19):1621. doi: 10.3390/cells13191621. Cells. 2024. PMID: 39404385 Free PMC article. Review.
-
Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment.Arch Pharm Res. 2024 Jul;47(7):632-644. doi: 10.1007/s12272-024-01505-1. Epub 2024 Jul 8. Arch Pharm Res. 2024. PMID: 38977652
References
-
- Dall’Era M, Cisternas MG, Snipes K, Herrinton LJ, Gordon C, Helmick CG. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol Hoboken NJ. 2017 Oct;69(10):1996–2005. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials